The unit of British American Tobacco Plc, Reynolds American Incannounced Friday that it has asked the US Food and Drug Administration for a review of its Vuse e-cigarette. This action gives Reynolds a head start on his main rival, Juul Labs Inc.
It is a real race against the clock that is launched in the United States. In fact, the FDA set a deadline of May 2020 for e-cigarette manufacturers to make a formal request to keep their products on the market, as part of its efforts to reduce the use of these in adolescents.
Reynolds, including electronic cigarettes Vuse provide nicotine via a cartridge-based spraying system, said to have provided the Food and Drug Administration (FDA) over 150 000 documentation pages, including information about the composition, design, and manufacturing processes associated with its product, as well as safety.
The company said it had also worked with a team of over 100 people to prepare the filing, including many regulatory and scientific experts.
US regulators are looking at ways to monitor the manufacture and marketing of electronic cigarettes as a result of increased use of these products among adolescents and the recent outbreak of a health scandal involving at least 29 victims in the US country.